U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Health Canada and FDA Joint Public Consultation on International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use - 04/03/2020 - 04/03/2020
  1. News & Events for Human Drugs

Conference

Event Title
Health Canada and FDA Joint Public Consultation on International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
April 3, 2020


Date:
April 3, 2020
Time:
10:00 AM - 1:00 PM ET

This meeting will now be held via webcast only.

The Food and Drug Administration (FDA) is announcing a regional public meeting entitled ‘‘Health Canada and United States Food and Drug Administration Joint Public Consultation on International Council for Harmonisation of Technical Requirements for Human Use (ICH)’’ to provide information and receive comments on the current activities of ICH as well as the upcoming meetings in Vancouver, Canada, in May 2020. The topics to be discussed are the topics for discussion at the forthcoming ICH Assembly Meeting. The purpose of the public meeting is to solicit public input prior to the next ICH Assembly meeting and the expert working groups meetings in Vancouver, Canada, scheduled for May 23 through 27, 2020, at which the discussion of the topics underway will continue.

Webcast (A website to access the webcast will be emailed to those who register for the meeting as a remote attendee – see Registration for details.)

Please note that this a webcast-only meeting, in-person attendance will not be accommodated.

Registration:

If you wish to attend the public meeting via webcast, please register at the following website: https://www.eventbrite.com/e/us-fda-and-health-canada-joint-regional-consultation-on-the-ich-tickets-86347946031. Registrations may be limited, so early registration is recommended. Registration is free and will be on a first-come, first-served basis. However, the number of participants from each organization may be limited based on space limitations. Registrants will receive confirmation once they have been accepted.

Meeting Materials

Contacts:

For more information: please contact William Lewallen, William.Lewallen@fda.hhs.gov

Back to Top